$69.34
+0.70 (+1.02%)
WGS News2 articles
GeneDx Shares Halved After Revenue Forecast Cut, Reimbursement Woes
GeneDx stock crashed 51% after slashing its 2026 revenue outlook, as reimbursement rates and product mix weighed on first-quarter results.
Analysts Slash Kingdee Target; JPMorgan, GeneDx, NCLH in Focus
Kingdee International's average price target was reduced to HK$15.78, while JPMorgan Chase shows signs of undervaluation. GeneDx and Norwegian Cruise Line shares decline amid valuation concerns.